Subscribe to the Print Version | Advertise | Submit Breaking News | Contact Us View email in your browser Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form. * Free print subscriptions are available to practicing physicians in the US.All others, applicable subscription charges apply. Bryn Mawr…
January 21, 2025—Aptyx, a Tempe, Arizona–based developer and manufacturer of complex components and devices for the life sciences, announc
January 23, 2025—Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark-approved COBRA-OS—Control of Bl
The knowns and unknowns about venous thrombus biology as it relates to in-stent restenosis and how these results drive patient care.
January 21, 2025—Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study o
January 20, 2025—Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu
Viz.ai is the leading AI care coordination platform for disease detection and workflow optimization. Trusted by 1,300 hospitals.
It is a wonderful honor to serve as Guest Editor of this venous disease–focused issue of Endovascular Today and collaborate with its outstan
January 17, 2025—R3 Vascular Inc. recently announced that it received WCG institutional review board (IRB) approval for the ELITE-BTK pivotal tr
January 16, 2025—Concept Medical Inc., announced the enrollment of the first patient in the pivotal MAGICAL BTK randomized controlled trial, whi
January 14, 2025—CereVasc, Inc. announced that the first patient was enrolled in the STRIDE clinical trial of the company’s eShunt system
